Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedNo detectable content changes between the screenshots; the study details page remains the same.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page now shows Revision: v3.4.2 and removes a government funding notice and an older Revision: v3.4.1; these are administrative metadata updates that do not affect study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedA new site-wide notice informs users about potential downtime due to a lapse in government funding and provides the NIH Clinical Center's operating status. The page also shows an updated revision tag, v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check27 days agoChange DetectedGlossary toggle added; study-record metadata label updated (Last Update Submitted that Met QC Criteria) and a new site revision note (Revision: v3.4.0) introduced, while older QC labels and FEAR data references were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; there are no substantive changes to the study details visible in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedNew study locations added: Barcelona, Murcia, and Valencia; page revision updated to v3.3.3.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.